New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
09:17 EDTAETAetna shares look cheap, says UBS
UBS said shares of Aetna look cheap following its Q2 results, citing valuation relative to peers, its favorable outlook on almost all of its operating metrics, and its increase in share buybacks. UBS has a Buy rating with a $93 price target on Aetna.
News For AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:51 EDTAETLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte provides outlook and favorite names for 2015 in the Hospitals and Managed Care Industry on an Analyst/Industry conference call to be held on December 18 at 1 pm.
December 12, 2014
13:52 EDTAETLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
08:46 EDTAETAetna price target raised to $103 from $92 at Credit Suisse
Credit Suisse raised Outperform rated Aetna's price target to $103 based on updated guidance and longer term growth opportunities.
08:03 EDTAETAetna 2015 EPS guidance cautious, says Wells Fargo
Subscribe for More Information
December 11, 2014
08:50 EDTAETAetna sees operating EPS highest in 1Q15
Subscribe for More Information
December 10, 2014
17:04 EDTAETAetna sees FY15 operating EPS at least $6.90, consensus $7.17
Sees FY15 operating revenue at least $62B, consensus $61.68B. Guidance to be confirmed at investor conference in New York on December 11.
17:02 EDTAETAetna backs FY14 operating EPS $6.60-$6.70, consensus $6.68
Subscribe for More Information
14:45 EDTAETDeal would block payments to health insurance companies, The Hill says
Subscribe for More Information
December 9, 2014
14:22 EDTAETAetna updates clinical policy for H.P. Acthar Gel
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use